Search
Search
About
Log in
Join
Experiences with
Ribavirin
Posts
Communities
96 public posts
Filter results
My Harvoni & Ribavirin treatment,6 weeks on.
Diagnosed in 2002 with Hepatitis C and now having treatment. I started 5th August last month and was so grateful i was given the chance to get rid, I was actually looking forward to it no matter how hard it was going to be . I mean this is my chance to sort my life out once and for all. So six weeks
Diagnosed in 2002 with Hepatitis C and now having treatment. I started 5th August last month and was so grateful i was given the chance to get rid, I was actually looking forward to it no matter how hard it was going to be . I mean this is my chance to sort my life out once and for all. So six weeks
scottyboy40
in
British Liver Trust
9 years ago
harvoni....day one.
So, two weeks on from my conciltation and today is a big day for me.Started taking 1x harvoni and 4x
ribavirin
today.Got another 12 weeks of this and hopefully i will be negative. To all those who are waiting for this treatment, i hope you all get your chance soon.
So, two weeks on from my conciltation and today is a big day for me.Started taking 1x harvoni and 4x
ribavirin
today.Got another 12 weeks of this and hopefully i will be negative. To all those who are waiting for this treatment, i hope you all get your chance soon.
scottyboy40
in
British Liver Trust
9 years ago
FDA approves Technivie for treatment of chronic hepatitis C genotype 4
Forty-four participants received Technivie once daily without
ribavirin
for 12 weeks.
Forty-four participants received Technivie once daily without
ribavirin
for 12 weeks.
kcohen
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Eyeing big returns, drugmakers ready new hepatitis-C drug launches
The FDA last week approved Technivie (ombitasvir, paritaprevir and ritonavir), to be used in combination with
ribavirin
to treat genotype-4 infections in patients without scarring and cirrhosis.
The FDA last week approved Technivie (ombitasvir, paritaprevir and ritonavir), to be used in combination with
ribavirin
to treat genotype-4 infections in patients without scarring and cirrhosis.
kcohen
in
HFI Connect - Hepatitis
9 years ago
ABBVIE ANNOUNCES NEW PHASE 3B RESULTS IN GENOTYPE 1B CHRONIC HEPATITIS C PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
Refer to the Summary of Product Characteristics for
ribavirin
for additional information.
Refer to the Summary of Product Characteristics for
ribavirin
for additional information.
kcohen
in
HFI Connect - Hepatitis
9 years ago
California could spend nearly $5 billion on HCV drugs over next year
The wholesale acquisition cost price of $117,000 is based on the following regimens: 8, 12 and 24 weeks of Harvoni (ledipasvir/sofosbuvir, Gilead Sciences) and 12 and 24 weeks of Sovaldi (sofosbuvir, Gilead Sciences) plus
ribavirin
.
The wholesale acquisition cost price of $117,000 is based on the following regimens: 8, 12 and 24 weeks of Harvoni (ledipasvir/sofosbuvir, Gilead Sciences) and 12 and 24 weeks of Sovaldi (sofosbuvir, Gilead Sciences) plus
ribavirin
.
kcohen
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and
ribavirin
.
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and
ribavirin
.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Merck Seeks FDA Approval of Hep C Tablet Grazoprevir/Elbasvir
Merck’s application is based in part on data from the C-EDGE, C-SURFER and C-SALVAGE clinical trials, which studied grazoprevir/elbasvir with and without
ribavirin
.
Merck’s application is based in part on data from the C-EDGE, C-SURFER and C-SALVAGE clinical trials, which studied grazoprevir/elbasvir with and without
ribavirin
.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Merck Seeks FDA Approval of Hep C Tablet Grazoprevir/Elbasvir
Merck’s application is based in part on data from the C-EDGE, C-SURFER and C-SALVAGE clinical trials, which studied grazoprevir/elbasvir with and without
ribavirin
.
Merck’s application is based in part on data from the C-EDGE, C-SURFER and C-SALVAGE clinical trials, which studied grazoprevir/elbasvir with and without
ribavirin
.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Preparing for Hepatitis C Treatment: Part 2
Alan FranciscusMedical Tests There may be tests your medical provider will order before you start treatment: Pregnancy test—If
ribavirin
is part of your treatment you will need to verify that you are not pregnant before starting treatment.
Alan FranciscusMedical Tests There may be tests your medical provider will order before you start treatment: Pregnancy test—If
ribavirin
is part of your treatment you will need to verify that you are not pregnant before starting treatment.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Daclatasvir Plus Sovaldi Shows Promise Curing Hard-to-Treat Hep C
Of all of the participants, a respective 64 and 15 percent took 24 weeks of treatment with or without
ribavirin
; and a respective 4 percent and 17 percent took 12 weeks of treatment with or without
ribavirin
. A total of 106 participants have made it to the four-week mark post-treatment.
Of all of the participants, a respective 64 and 15 percent took 24 weeks of treatment with or without
ribavirin
; and a respective 4 percent and 17 percent took 12 weeks of treatment with or without
ribavirin
. A total of 106 participants have made it to the four-week mark post-treatment.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Cure for Almost All Hep C-Positive Liver Transplantees
Thirty-eight percent received
ribavirin
.
Thirty-eight percent received
ribavirin
.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Hepatitis C - The Long Goodbye
She endured two rounds of interferon and
ribavirin
treatment, requiring self injecting toxins, directly into her stomach. For a time after that, she seemed better. We all breathed a sigh of relief and prayed it was gone.
She endured two rounds of interferon and
ribavirin
treatment, requiring self injecting toxins, directly into her stomach. For a time after that, she seemed better. We all breathed a sigh of relief and prayed it was gone.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Coffee and the Liver
Those who had hepatitis C-related bridging fibrosis or cirrhosis on a liver biopsy and who failed to achieve a cure after being treated with pegylated interferon and
ribavirin
therapy also yielded some surprising results.
Those who had hepatitis C-related bridging fibrosis or cirrhosis on a liver biopsy and who failed to achieve a cure after being treated with pegylated interferon and
ribavirin
therapy also yielded some surprising results.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and
ribavirin
.
Included in the list are Gilead Sciences’ Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir), Janssen’s Olysio (simeprevir), Bristol-Myers Squibb’s daclatasvir, and the two components of AbbVie’s Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir), as well as interferon and
ribavirin
.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
WHO Adds New Hepatitis C Drugs to Essential Medicines List
Specifically, the WHO added sofosbuvir (brand name Sovaldi) to the guide, as well as simeprevir (Olysio), daclatasvir,
ribavirin
and the non-nucleoside polymerase inhibitor dasabuvir.
Specifically, the WHO added sofosbuvir (brand name Sovaldi) to the guide, as well as simeprevir (Olysio), daclatasvir,
ribavirin
and the non-nucleoside polymerase inhibitor dasabuvir.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Exviera, Viekirax combination added benefit for patients with HCV without cirrhosis
treated with a combination of Incivek (telaprevir, Vertex), pegylated interferon and
ribavirin
, according to the release.
treated with a combination of Incivek (telaprevir, Vertex), pegylated interferon and
ribavirin
, according to the release.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
FDA Grants Priority Review for AbbVie's Hepatitis C Treatment
Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with
ribavirin
(RBV).
Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with
ribavirin
(RBV).
mwright
in
HFI Connect - Hepatitis
9 years ago
Daclatasvir and Sovaldi Cure High Rates of Genotype 1 of Hep C
A recent trial suggests that Bristol-Myers Squibb’s daclatasvir plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without
ribavirin
, cures high rates of people with genotype 1 of hepatitis C virus (HCV), including those with cirrhosis.
A recent trial suggests that Bristol-Myers Squibb’s daclatasvir plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without
ribavirin
, cures high rates of people with genotype 1 of hepatitis C virus (HCV), including those with cirrhosis.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Harvoni Beats Hep C Among Those With Advanced Liver Disease
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and
ribavirin
cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports.
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) and
ribavirin
cures hepatitis C virus (HCV) at mostly high rates among those with decompensated cirrhosis or who have had recurrent hep C after a liver transplant, MedPage Today reports.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
1
...
3
4
5
Next page
Filter results
Clear filters
Posted in
All communities
HFI Connect - Hepatitis
30 results
British Liver Trust
21 results
Hepatitis C Trust
19 results
View top 10 communities
Sort by
Most Relevant
Newest